New antiviral may offer ‘less cumbersome’ COVID treatment option The Chinese-developed oral antiviral reportedly achieves similar outcomes to Paxlovid, but with fewer side effects and drug–drug interactions.
Which baby sleep interventions are most effective? With many parents now using behavioural sleep interventions, a new study examines which of the most common work best and cause the least harm.
New year brings cheaper medicines The maximum cost of subsidised prescriptions has been cut for the first time since the PBS was introduced 75 years ago.
RACGP pushes for greater reproductive healthcare access A college submission has called for changes aimed at making abortion and contraceptive services more affordable and accessible.
Codeine use down by 37% since up-scheduling Use of the drug has dropped substantially across all jurisdictions, a new wastewater-based epidemiology report suggests.
Taskforce seeks to double blood pressure control rates by 2030 Only half of the people in Australia with high blood pressure know they have it, and of those, only 32% have it under control.
Pharmacy prescribing will worsen antibiotic shortage: RACGP President The trimethoprim shortage is another reason why allowing pharmacists to prescribe antibiotics is problematic, Dr Nicole Higgins has warned.
Breakthrough in mRNA vaccines for melanoma Preliminary research shows personalised melanoma mRNA vaccines given with an immunotherapy drug reduce risk of death and recurrence.
‘Disappointing news’: Government pulls Clinical Taskforce funding Formed in response to the COVID-19 pandemic, the National Clinical Evidence Taskforce still hopes to attract support for its work.
Study reveals global burden of early T2DM The number of young people with type 2 diabetes has risen substantially in the past 30 years, research involving more than 200 countries shows.